Valley Brook Capital Group
- SEC CIK
- 0001851418
- Latest filing
- Jul 27, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Valley Brook Capital Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 23,146
- Value
- $5.82M
- % of portfolio
- 3.3%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 23,146 | $5.82M | 3.3% | +183+0.8% | Added | Holders |
| Q1 2026 | 22,963 | $4.99M | 3.3% | −103−0.4% | Reduced | Holders |
| Q4 2025 | 23,066 | $5.27M | 3.5% | +146+0.6% | Added | Holders |
| Q3 2025 | 22,920 | $5.31M | 3.6% | +128+0.6% | Added | Holders |
| Q2 2025 | 22,792 | $4.23M | 3.2% | −125−0.5% | Reduced | Holders |
| Q1 2025 | 22,917 | $4.80M | 3.8% | +218+1.0% | Added | Holders |
| Q4 2024 | 22,699 | $4.03M | 3.0% | −88−0.4% | Reduced | Holders |
| Q3 2024 | 22,787 | $4.50M | 3.2% | −58−0.3% | Reduced | Holders |
| Q2 2024 | 22,845 | $3.92M | 3.1% | +96+0.4% | Added | Holders |
| Q1 2024 | 22,749 | $4.14M | 3.3% | −96−0.4% | Reduced | Holders |
| Q4 2023 | 22,845 | $3.54M | 3.1% | +128+0.6% | Added | Holders |
| Q3 2023 | 22,717 | $3.39M | 3.3% | +468+2.1% | Added | Holders |
| Q2 2023 | 22,249 | $3.00M | 2.8% | −891−3.9% | Reduced | Holders |
| Q1 2023 | 23,140 | $3.69M | 3.4% | −239−1.0% | Reduced | Holders |
| Q4 2022 | 23,379 | $3.78M | 3.6% | +357+1.6% | Added | Holders |
| Q3 2022 | 23,022 | $3.09M | 3.4% | +107+0.5% | Added | Holders |
| Q2 2022 | 22,915 | $3.51M | 3.6% | −400−1.7% | Reduced | Holders |
| Q1 2022 | 23,315 | $3.78M | 3.3% | +1,206+5.5% | Added | Holders |
| Q4 2021 | 22,109 | $2.99M | 2.6% | +208+0.9% | Added | Holders |
| Q3 2021 | 21,901 | $2.36M | 2.3% | −1,123−4.9% | Reduced | Holders |
| Q2 2021 | 23,024 | $2.59M | 2.5% | +627+2.8% | Added | Holders |
| Q1 2021 | 22,397 | $2.42M | 2.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.